Korbinian Löbmann is co-founder and CSO of ZERION and the lead inventor behind the company’s Dispersome® technology for improving the solubility of small molecule drugs. Dr. Löbmann has a strong track record in pharmaceutical formulation and drug delivery. He has 10 years of experience in solid formulation and dosage form development, including preformulation, formulation, processing and manufacturing together with the relevant solid state characterization and quality control. This includes in particular the development of new enabling formulation strategies for poorly soluble drugs using amorphous drug delivery systems. Korbinian Löbmann received his PhD in pharmaceutical sciences in 2013 from the University of Otago, New Zealand.